These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis. Shetty S, John B, Mohan S, Paul TV. Arch Osteoporos; 2020 Feb 24; 15(1):25. PubMed ID: 32095943 [Abstract] [Full Text] [Related]
4. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada. Leslie WD, Lix LM, Binkley N. Arch Osteoporos; 2020 Jun 23; 15(1):93. PubMed ID: 32577922 [Abstract] [Full Text] [Related]
5. Bone mineral density measurement combined with vertebral fracture assessment increases diagnosis of osteoporosis in postmenopausal women. Cai S, Yu H, Li Y, He X, Yan L, Huang X, Wang P. Skeletal Radiol; 2020 Feb 23; 49(2):273-280. PubMed ID: 31352490 [Abstract] [Full Text] [Related]
7. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study. Esmaeilzadeh S, Cesme F, Oral A, Yaliman A, Sindel D. Endocr Res; 2016 Aug 23; 41(3):248-60. PubMed ID: 26864472 [Abstract] [Full Text] [Related]
10. Clinical risk factor status in patients with vertebral fracture but normal bone mineral density. Kadri A, Binkley N, Daffner SD, Anderson PA. Spine J; 2022 Oct 23; 22(10):1634-1641. PubMed ID: 35680015 [Abstract] [Full Text] [Related]
12. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool. Lin J, Yang Y, Fei Q, Zhang X, Ma Z, Wang Q, Li J, Li D, Meng Q, Wang B. Clin Interv Aging; 2016 Oct 23; 11():461-9. PubMed ID: 27217730 [Abstract] [Full Text] [Related]
13. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice. Watts NB. J Womens Health (Larchmt); 2011 Apr 23; 20(4):525-31. PubMed ID: 21438699 [Abstract] [Full Text] [Related]
14. Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold. Wang Y, Yu S, Hsu C, Tsai C, Cheng T. Osteoporos Int; 2020 Mar 23; 31(3):475-483. PubMed ID: 31696272 [Abstract] [Full Text] [Related]
15. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data. Bastos-Silva Y, Aguiar LB, Pinto-Neto AM, Baccaro LF, Costa-Paiva L. Arch Osteoporos; 2016 Mar 23; 11():16. PubMed ID: 27067597 [Abstract] [Full Text] [Related]
16. Fracture Risk Assessment Tool (FRAX®) Results Calculated With and Without Bone Mineral Density Values for the Evaluation of Fracture Risk in Postmenopausal Women With Osteopenia. Imerci A, Yalın Kılınç C, Aydogan NH, Karalezli MN, Savran A. J Clin Densitom; 2018 Mar 23; 21(4):464-471. PubMed ID: 28781230 [Abstract] [Full Text] [Related]
17. Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures. Ahmed LA, Shigdel R, Joakimsen RM, Eldevik OP, Eriksen EF, Ghasem-Zadeh A, Bala Y, Zebaze R, Seeman E, Bjørnerem Å. Osteoporos Int; 2015 Aug 23; 26(8):2137-46. PubMed ID: 25876879 [Abstract] [Full Text] [Related]
18. Discordance in lumbar bone mineral density measurements by quantitative computed tomography and dual-energy X-ray absorptiometry in postmenopausal women: a prospective comparative study. Lin W, He C, Xie F, Chen T, Zheng G, Yin H, Chen H, Wang Z. Spine J; 2023 Feb 23; 23(2):295-304. PubMed ID: 36343911 [Abstract] [Full Text] [Related]
19. Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools. Bonaccorsi G, Messina C, Cervellati C, Maietti E, Medini M, Rossini M, Massari L, Greco P. Gynecol Endocrinol; 2018 May 23; 34(5):404-408. PubMed ID: 29172781 [Abstract] [Full Text] [Related]
20. Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV. Vizcarra P, Gallego J, Vivancos MJ, Sifuentes WA, Llop M, Casado JL. HIV Res Clin Pract; 2020 May 23; 21(2-3):63-71. PubMed ID: 32698706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]